Drug Trial Radar · NCT06456580
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
191
Actual
Start
Jul 17, 2024
Primary completion
Mar 2027
Study completion Jan 2029
Sponsor
- Lead sponsor
- Vor BiopharmaIndustry
- Sponsor type
- Industry
- First posted
- Jun 13, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of generalized myasthenia gravis.
Conditions
- Generalized Myasthenia Gravis
Interventions
TelitaciceptBiological
Subcutaneous injection
PlaceboDrug
Subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Myasthenia Gravis-Activities of Daily Living (MG-ADL) score at Week 24Time frame: Week 24
Locations
120 sites in 15 countries. Site status is shown where the registry gives one.
HonorHealth Neurology - Bob Bové Neuroscience Institute
Scottsdale, Arizona
University of Southern California
Los Angeles, California
University of California Irvine
Orange, California
University of California San Francisco (UCSF)
San Francisco, California
SFM Clinical Research
Boca Raton, Florida
BayCare Medical Group - Clearwater
Clearwater, Florida
Allied Biomedical Research Institute (ABRI)
Miami, Florida
Medsol Clinical Research Center
Port Charlotte, Florida
University of South Florida Health (USF Health)
Tampa, Florida
Wellstar MCG Health Medical Center
Augusta, Georgia
Hospital Sisters Health System Medical
O'Fallon, Illinois
University of Kansas Medical Center
Kansas City, Kansas
University of Kentucky
Lexington, Kentucky
University of Louisville Physicians
Louisville, Kentucky
Neurology Center of New England
Foxborough, Massachusetts
Michigan State University Clinical Center
East Lansing, Michigan
Trinity Health - Grand Rapids Hospital
Grand Rapids, Michigan
UM Health Care - Neurology and Sleep Disorders Clinic
Columbia, Missouri
Robert Wood Johnson University Hospital New Brunswick
New Brunswick, New Jersey
Lange Neurology
New York, New York
Mount Sinai Health System
New York, New York
Montefiore Medical Center
The Bronx, New York
University of North Carolina Hospitals - Neurology Clinic
Chapel Hill, North Carolina
University of Cincinnati Health Physicians - Clifton
Cincinnati, Ohio
Empower Clinical Research
Tigard, Oregon
University of Tennessee Medical Center
Knoxville, Tennessee
University of Texas Southwestern Medical Center
Dallas, Texas
Neurology Rare Disease Center
Flower Mound, Texas
Houston Methodist Neurological Institute
Houston, Texas
Center for Neurological Disorders, S.C. - Greenfield - Gamma Therapeutic Center
Greenfield, Wisconsin
Fundación Scherbovsky
Mendoza, Argentina
STAT Research S.A.
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Hospital Italiano de Buenos Aires
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Hospital General de Agudos José María Ramos Mejía
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
INECO Neurociencias Oroño
Rosario, Santa Fe Province, Argentina
Concord Repatriation General Hospital
Concord, New South Wales, Australia
Townsville University Hospital
Douglas, Queensland, Australia
Gold Coast University Hospital
Southport, Queensland, Australia
Centre Hospitalier Régional de la Citadelle
Liège, Belgium
Universitair Ziekenhuis (UZ) Leuven - Campus Gasthuisberg
Leuven, Flemish Brabant, Belgium
Showing 40 of 120 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.